Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

1.

Behavioral and neurochemical effects of chronic L-DOPA treatment on nonmotor sequelae in the hemiparkinsonian rat.

Eskow Jaunarajs KL, Dupre KB, Ostock CY, Button T, Deak T, Bishop C.

Behav Pharmacol. 2010 Oct;21(7):627-37. doi: 10.1097/FBP.0b013e32833e7e80.

PMID:
20838211
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

High-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease.

Navailles S, Benazzouz A, Bioulac B, Gross C, De Deurwaerdère P.

J Neurosci. 2010 Feb 10;30(6):2356-64. doi: 10.1523/JNEUROSCI.5031-09.2010.

PMID:
20147561
[PubMed - indexed for MEDLINE]
Free Article
3.

Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease.

Navailles S, Bioulac B, Gross C, De Deurwaerdère P.

Neurobiol Dis. 2010 Apr;38(1):136-43. doi: 10.1016/j.nbd.2010.01.012. Epub 2010 Jan 22.

PMID:
20096781
[PubMed - indexed for MEDLINE]
4.

From synapse to nucleus: novel targets for treating depression.

Covington HE 3rd, Vialou V, Nestler EJ.

Neuropharmacology. 2010 Mar-Apr;58(4-5):683-93. doi: 10.1016/j.neuropharm.2009.12.004. Epub 2009 Dec 17. Review.

PMID:
20018197
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study.

Nègre-Pagès L, Grandjean H, Lapeyre-Mestre M, Montastruc JL, Fourrier A, Lépine JP, Rascol O; DoPaMiP Study Group.

Mov Disord. 2010 Jan 30;25(2):157-66. doi: 10.1002/mds.22760.

PMID:
19950403
[PubMed - indexed for MEDLINE]
6.

Responsiveness of motor and nonmotor symptoms of Parkinson disease to dopaminergic therapy.

Stacy MA, Murck H, Kroenke K.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):57-61. doi: 10.1016/j.pnpbp.2009.09.023. Epub 2009 Sep 28.

PMID:
19793544
[PubMed - indexed for MEDLINE]
7.

Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment.

Kim HJ, Park SY, Cho YJ, Hong KS, Cho JY, Seo SY, Lee DH, Jeon BS.

J Neurol Sci. 2009 Dec 15;287(1-2):200-4. doi: 10.1016/j.jns.2009.07.026. Epub 2009 Aug 22.

PMID:
19700173
[PubMed - indexed for MEDLINE]
8.

Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation.

Nayyar T, Bubser M, Ferguson MC, Neely MD, Shawn Goodwin J, Montine TJ, Deutch AY, Ansah TA.

Eur J Neurosci. 2009 Jul;30(2):207-16. doi: 10.1111/j.1460-9568.2009.06806.x.

PMID:
19659923
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease.

Aarsland D, Brønnick K, Alves G, Tysnes OB, Pedersen KF, Ehrt U, Larsen JP.

J Neurol Neurosurg Psychiatry. 2009 Aug;80(8):928-30. doi: 10.1136/jnnp.2008.166959.

PMID:
19608786
[PubMed - indexed for MEDLINE]
10.

Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity.

Taylor TN, Caudle WM, Shepherd KR, Noorian A, Jackson CR, Iuvone PM, Weinshenker D, Greene JG, Miller GW.

J Neurosci. 2009 Jun 24;29(25):8103-13. doi: 10.1523/JNEUROSCI.1495-09.2009.

PMID:
19553450
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease.

Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SA, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Rabins PV, Weiss HD, Marsh L.

Mov Disord. 2009 Jul 15;24(9):1333-8. doi: 10.1002/mds.22611.

PMID:
19425086
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease.

Menza M, Dobkin RD, Marin H, Mark MH, Gara M, Buyske S, Bienfait K, Dicke A.

Mov Disord. 2009 Jul 15;24(9):1325-32. doi: 10.1002/mds.22586.

PMID:
19412944
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Relationship between depression and cognitive dysfunctions in Parkinson's disease without dementia.

Santangelo G, Vitale C, Trojano L, Longo K, Cozzolino A, Grossi D, Barone P.

J Neurol. 2009 Apr;256(4):632-8. doi: 10.1007/s00415-009-0146-5. Epub 2009 Apr 15.

PMID:
19370301
[PubMed - indexed for MEDLINE]
14.

The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats.

Eskow KL, Dupre KB, Barnum CJ, Dickinson SO, Park JY, Bishop C.

Synapse. 2009 Jul;63(7):610-20. doi: 10.1002/syn.20630.

PMID:
19309758
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Validation of the Chinese non-motor symptoms scale for Parkinson's disease: results from a Chinese pilot study.

Wang G, Hong Z, Cheng Q, Xiao Q, Wang Y, Zhang J, Ma JF, Wang XJ, Zhou HY, Chen SD.

Clin Neurol Neurosurg. 2009 Jul;111(6):523-6. doi: 10.1016/j.clineuro.2009.02.005. Epub 2009 Mar 17.

PMID:
19297081
[PubMed - indexed for MEDLINE]
16.

Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease.

Tadaiesky MT, Dombrowski PA, Figueiredo CP, Cargnin-Ferreira E, Da Cunha C, Takahashi RN.

Neuroscience. 2008 Oct 28;156(4):830-40. doi: 10.1016/j.neuroscience.2008.08.035. Epub 2008 Sep 9.

PMID:
18817851
[PubMed - indexed for MEDLINE]
17.

Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders.

Wood MD, Wren PB.

Prog Brain Res. 2008;172:213-30. doi: 10.1016/S0079-6123(08)00911-4. Review.

PMID:
18772035
[PubMed - indexed for MEDLINE]
18.

Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.

Vucković MG, Wood RI, Holschneider DP, Abernathy A, Togasaki DM, Smith A, Petzinger GM, Jakowec MW.

Neurobiol Dis. 2008 Nov;32(2):319-27. doi: 10.1016/j.nbd.2008.07.015. Epub 2008 Aug 5.

PMID:
18718537
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Molecular mechanisms of L-DOPA-induced dyskinesia.

Jenner P.

Nat Rev Neurosci. 2008 Sep;9(9):665-77. doi: 10.1038/nrn2471. Review.

PMID:
18714325
[PubMed - indexed for MEDLINE]
20.

Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia.

Kulisevsky J, Pagonabarraga J, Pascual-Sedano B, García-Sánchez C, Gironell A; Trapecio Group Study.

Mov Disord. 2008 Oct 15;23(13):1889-96. doi: 10.1002/mds.22246.

PMID:
18709682
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk